- Home
- ESPR vs CGNT Comparison
ESPR vs CGNT Comparison
Compare ESPR & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CGNT
- Stock Information
- Founded
- ESPR 2008
- CGNT 2020
- Country
- ESPR United States
- CGNT Israel
- Employees
- ESPR N/A
- CGNT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- ESPR Health Care
- CGNT Technology
- Exchange
- ESPR Nasdaq
- CGNT Nasdaq
- Market Cap
- ESPR 534.3M
- CGNT 617.3M
- IPO Year
- ESPR 2013
- CGNT N/A
- Fundamental
- Price
- ESPR $2.97
- CGNT $8.35
- Analyst Decision
- ESPR Buy
- CGNT Buy
- Analyst Count
- ESPR 6
- CGNT 2
- Target Price
- ESPR $6.50
- CGNT $14.00
- AVG Volume (30 Days)
- ESPR 7.1M
- CGNT 284.4K
- Earning Date
- ESPR 11-06-2025
- CGNT 12-10-2025
- Dividend Yield
- ESPR N/A
- CGNT N/A
- EPS Growth
- ESPR N/A
- CGNT N/A
- EPS
- ESPR N/A
- CGNT N/A
- Revenue
- ESPR $268,125,000.00
- CGNT $376,566,000.00
- Revenue This Year
- ESPR $18.83
- CGNT $15.30
- Revenue Next Year
- ESPR N/A
- CGNT $11.30
- P/E Ratio
- ESPR N/A
- CGNT N/A
- Revenue Growth
- ESPR N/A
- CGNT 14.04
- 52 Week Low
- ESPR $0.69
- CGNT $6.38
- 52 Week High
- ESPR $3.94
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- ESPR 59.21
- CGNT 49.93
- Support Level
- ESPR $2.80
- CGNT $7.82
- Resistance Level
- ESPR $3.11
- CGNT $8.59
- Average True Range (ATR)
- ESPR 0.17
- CGNT 0.18
- MACD
- ESPR 0.01
- CGNT 0.04
- Stochastic Oscillator
- ESPR 76.47
- CGNT 68.83
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.